Merck & Co., Inc. (MRK) Latest Stock News & Headlines - Yahoo ...
Get the latest Merck & Co., Inc. (MRK) stock news and headlines to help you in your trading and investing decisions.
Gilead, MRK Report Data From Investigational Combination ...
1 day ago · Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational combination of islatravir and lenacapavir for the treatment of HIV.
Investor relations - Merck.com
Oct 16, 2024 · Merck’s (NYSE: MRK) Q1 2024 results reflect continued strong growth in oncology and vaccines. Our company announced Q1 worldwide sales of $15.8 billion, an increase of 9% from Q1 2023. “Merck has begun 2024 with continuing momentum in our business.
Merck & Co., Inc. (MRK) Stock Price, News, Quote & History ...
Find the latest Merck & Co., Inc. (MRK) stock quote, history, news and other vital information to help you with your stock trading and investing.
Merck & Co., Inc. (MRK) Stock Price, Quote, News & Analysis
5 days ago · A high-level overview of Merck & Co., Inc. (MRK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
News releases - Merck.com
Oct 14, 2024 · FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM) Items per page.
MRK Stock Quote Price and Forecast | CNN
5 days ago · View Merck & Co., Inc. MRK stock quote prices, financial information, real-time forecasts, and company news from CNN.